In vitro and in vivo experiments, previously performed by our group, showed that KCa3.1 silencing or inhibition with the KCa3.1 blockers senicapoc or TRAM-34 impair migration, invasion, proliferation and tumor growth [15, 16]. Here, KCNN4 is linked to neoplasm.